ST. LOUIS (CN) — Novartis Pharmacy hopes a recent ruling by the Eighth Circuit will bolster its efforts in the same court to block a Missouri law requiring the drug giant to give medical providers unlimited access to discounted drugs for their pharmacies.
The law, Senate Bill 751, requires drugmakers to accept orders for providers eligible for discounts under the 340B program, a federal initiative designed to serve low-income and uninsured patients by offering more comprehensive medical services. The law allows these providers to have an unlimited number of contracts with pharmacies.
Read Full Article: https://www.courthousenews.com/fighting-missouri-drug-discounts-at-eighth-circuit-novartis-points-to-recent-ruling-from-court/
